Company MEI Pharma, Inc. Börse Stuttgart
Equities
MMI0
US55279B3015
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.272 EUR | +0.38% | +1,961.78% | +1,757.39% |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Compounds
100.0
%
| 41 | 100.0 % | 49 | 100.0 % | +19.95% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 41 | 100.0 % | 49 | 100.0 % | +19.95% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Urso
CEO | Chief Executive Officer | 60 | 07/14/07 |
Justin File
DFI | Director of Finance/CFO | 53 | 12/23/12 |
Caroline Ruiz
CTO | Chief Tech/Sci/R&D Officer | - | 01/22/01 |
Eric Deng
CTO | Chief Tech/Sci/R&D Officer | - | 01/21/01 |
Jason Sausser
CTO | Chief Tech/Sci/R&D Officer | - | 01/22/01 |
Richard Ghalie
CTO | Chief Tech/Sci/R&D Officer | 66 | 01/16/01 |
David Walsey
IRC | Investor Relations Contact | - | 01/18/01 |
Eugene Park
SAM | Sales & Marketing | - | 01/21/01 |
Anne Frese
HRO | Human Resources Officer | - | 22/22/22 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Fred Driscoll
BRD | Director/Board Member | 73 | 26/18/26 |
Thomas Reynolds
BRD | Director/Board Member | 65 | 11/13/11 |
Charles Baltic
CHM | Chairman | 63 | 20/11/20 |
Nick Glover
BRD | Director/Board Member | 55 | 11/13/11 |
David Urso
CEO | Chief Executive Officer | 60 | 07/14/07 |
Steven Wood
BRD | Director/Board Member | 41 | 31/23/31 |
Director/Board Member | 33 | 31/23/31 | |
James Flynn
BRD | Director/Board Member | 43 | 31/23/31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 6,662,857 | 6,616,017 ( 99.30 %) | 0 | 99.30 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+40.80% | 5.37TCr | |
+35.79% | 3.89TCr | |
-8.05% | 3.88TCr | |
-8.98% | 2.73TCr | |
+10.69% | 2.59TCr | |
-16.21% | 2.03TCr | |
+31.00% | 1.28TCr | |
+28.51% | 1.22TCr | |
-1.67% | 1.2TCr |
- Stock Market
- Equities
- MEIP Stock
- MMI0 Stock
- Company MEI Pharma, Inc.